Hikal Limited (NSE: HIKAL) is a leading Indian life sciences company with a global presence. The company specializes in developing and manufacturing intermediates, active pharmaceutical ingredients (APIs), and specialty chemicals for the pharmaceutical, agrochemical, and animal health industries. HIKAL has a strong focus on innovation and quality, which has helped it establish a leading position in the market.
In terms of earnings, Revenue from Operations for Q3 FY23 was ₹538.45 crore, a 6% increase from ₹506.62 crore in the same period last year. The Pharmaceutical segment generated a total of ₹292.18 Crore in revenue, or 54% of the total revenue. The Crop protection segment which reported revenue of ₹248.02 Crore, accounted for the remaining percent of the overall Revenue. The Consolidated Net Profit was ₹26.41 crore, down 41% from ₹45.2 crore in the same quarter last year. This quarter’s earnings per share was ₹2.14.
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,